A new study suggests that taking aspirin three times a week or more can give patients with cancer a better chance of surviving the disease.
A National Institutes of Health (NIH) study that followed more than 140,000 Americans found that those who adhered to an aspirin regime were at a lower risk of developing prostate, colorectal, lung, or ovarian cancer.
The benefits, however, seem to apply only to normal-weight people. For people who are underweight or overweight, taking aspirin had no consequences.
Experts say that the fact that so many people are included in the analysis is promising, but warn that other factors, such as the likelihood that the same type of people who regularly take aspirin, are generally healthier.